| scholarly article | Q13442814 |
| P50 | author | Tony Wyss-Coray | Q23782672 |
| P2093 | author name string | Eva Czirr | |
| P2860 | cites work | Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease | Q23916366 |
| Use of ibuprofen and risk of Parkinson disease | Q24594751 | ||
| The ageing systemic milieu negatively regulates neurogenesis and cognitive function. | Q24599219 | ||
| Association between acute care and critical illness hospitalization and cognitive function in older adults | Q24602638 | ||
| Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration | Q24614960 | ||
| Exploring the full spectrum of macrophage activation | Q24653754 | ||
| Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo | Q27860578 | ||
| Astrocyte-endothelial interactions at the blood-brain barrier | Q28131675 | ||
| Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery | Q28199892 | ||
| The danger model: a renewed sense of self | Q28214633 | ||
| Reflex control of immunity | Q28245909 | ||
| The classical complement cascade mediates CNS synapse elimination | Q28261273 | ||
| Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction | Q28266358 | ||
| CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. | Q28344579 | ||
| Down-regulation of the macrophage lineage through interaction with OX2 (CD200) | Q28505224 | ||
| Control of microglial neurotoxicity by the fractalkine receptor | Q28513748 | ||
| Toll-like receptor 4 is a sensor for autophagy associated with innate immunity | Q28513852 | ||
| The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice | Q28591283 | ||
| Microglia: active sensor and versatile effector cells in the normal and pathologic brain | Q29547240 | ||
| Toll-like receptor control of the adaptive immune responses | Q29547305 | ||
| Circulating mitochondrial DAMPs cause inflammatory responses to injury | Q29614470 | ||
| Synaptic pruning by microglia is necessary for normal brain development | Q29615591 | ||
| Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration | Q44748602 | ||
| Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins | Q44917427 | ||
| Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease | Q45877904 | ||
| TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. | Q45972218 | ||
| CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function. | Q46036847 | ||
| Characterization and immune function of two intracellular sensors, HmTLR1 and HmNLR, in the injured CNS of an invertebrate | Q48062557 | ||
| Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease | Q48247414 | ||
| Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration. | Q48358396 | ||
| Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. | Q48459353 | ||
| Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. | Q48586335 | ||
| Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. | Q48708288 | ||
| Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. | Q48736659 | ||
| Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. | Q48741510 | ||
| Complement facilitates early prion pathogenesis. | Q48930440 | ||
| Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. | Q49160789 | ||
| CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. | Q51011935 | ||
| Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. | Q51039637 | ||
| A gene expression pattern in blood for the early detection of Alzheimer's disease. | Q51650279 | ||
| Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year. | Q51912744 | ||
| Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. | Q52544555 | ||
| Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. | Q53220157 | ||
| Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice. | Q53264743 | ||
| Caspase signalling controls microglia activation and neurotoxicity. | Q53422658 | ||
| CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. | Q54699382 | ||
| NSAIDs and incident Alzheimer’s disease. the Rotterdam study | Q57782138 | ||
| Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease | Q68099264 | ||
| Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis | Q72208007 | ||
| Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells | Q73948765 | ||
| Superoxide dismutase 1 regulates caspase-1 and endotoxic shock | Q81588114 | ||
| Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry | Q29615618 | ||
| Toll-like receptors control autophagy. | Q30481722 | ||
| Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease | Q30581719 | ||
| Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice | Q33742156 | ||
| Systemic inflammation and disease progression in Alzheimer disease | Q33765718 | ||
| Multiple changes in peptide and lipid expression associated with regeneration in the nervous system of the medicinal leech | Q33883610 | ||
| Cell mediators of inflammation in the Alzheimer disease brain | Q33941244 | ||
| The myeloid cells of the central nervous system parenchyma | Q34024675 | ||
| Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. | Q34059225 | ||
| Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice | Q34076162 | ||
| Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology | Q34169743 | ||
| Regulation of tau pathology by the microglial fractalkine receptor | Q34179654 | ||
| Prion pathogenesis in the absence of Toll-like receptor signalling | Q34227964 | ||
| CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. | Q34254575 | ||
| ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis | Q34258672 | ||
| Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline | Q34377379 | ||
| Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu | Q34383143 | ||
| HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. | Q34615988 | ||
| Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta | Q34721090 | ||
| CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice | Q34744169 | ||
| Inflammation in neurodegenerative disease--a double-edged sword | Q34775762 | ||
| Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition | Q34878224 | ||
| Toll-like receptor signaling in neural plasticity and disease | Q34984865 | ||
| Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice | Q34985230 | ||
| The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice | Q35014661 | ||
| Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy | Q35015949 | ||
| Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6. | Q35057271 | ||
| Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition | Q35087794 | ||
| Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology | Q35112497 | ||
| Three or more routes for leukocyte migration into the central nervous system | Q35183162 | ||
| Signaling via the prostaglandin E₂ receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia | Q35484819 | ||
| Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. | Q35497573 | ||
| Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice | Q35750144 | ||
| Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology | Q35813745 | ||
| Can autophagy protect against neurodegeneration caused by aggregate-prone proteins? | Q35945776 | ||
| Cholinergic control of inflammation | Q35966390 | ||
| Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice | Q36119066 | ||
| The HMGB1 receptor RAGE mediates ischemic brain damage | Q36134557 | ||
| UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis | Q36298197 | ||
| Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease | Q36320351 | ||
| CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis | Q36369098 | ||
| Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia | Q36487090 | ||
| Role of toll-like receptor signalling in Abeta uptake and clearance | Q36745996 | ||
| Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression | Q36868802 | ||
| CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. | Q36899833 | ||
| Systemic and acquired immune responses in Alzheimer's disease | Q36902286 | ||
| Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation | Q36916025 | ||
| Autophagic control of listeria through intracellular innate immune recognition in drosophila | Q36925388 | ||
| T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. | Q36968498 | ||
| Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease | Q36998952 | ||
| Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. | Q37036090 | ||
| Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology | Q37113528 | ||
| IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice | Q37232963 | ||
| TLR9 is localized in the endoplasmic reticulum prior to stimulation | Q37377551 | ||
| All-you-can-eat: autophagy in neurodegeneration and neuroprotection. | Q37434629 | ||
| Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease | Q37480839 | ||
| An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease | Q37546119 | ||
| The neurology of the immune system: neural reflexes regulate immunity | Q37617617 | ||
| Heterogeneity of CNS myeloid cells and their roles in neurodegeneration | Q37939514 | ||
| Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer's disease. | Q39630665 | ||
| Autophagy protects against Sindbis virus infection of the central nervous system | Q39738841 | ||
| A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. | Q40005550 | ||
| RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice | Q40251711 | ||
| Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. | Q40496060 | ||
| Subcellular localization of Toll-like receptor 3 in human dendritic cells | Q40636721 | ||
| Fractalkine and fractalkine receptors in human neurons and glial cells | Q40717328 | ||
| Rate of cell death in parkinsonism indicates active neuropathological process | Q41417978 | ||
| GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. | Q41611744 | ||
| Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease | Q41753192 | ||
| Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice | Q42001466 | ||
| Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease | Q43736405 | ||
| Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. | Q44241464 | ||
| α-Synuclein Is Degraded by Both Autophagy and the Proteasome | Q44420467 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 1156-1163 | |
| P577 | publication date | 2012-04-02 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | The immunology of neurodegeneration | |
| P478 | volume | 122 |
| Q30584294 | A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study |
| Q26824941 | A revival of parabiosis in biomedical research |
| Q37209334 | AIM 2 inflammasomes regulate neuronal morphology and influence anxiety and memory in mice |
| Q40846982 | Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. |
| Q37043414 | Allergy Enhances Neurogenesis and Modulates Microglial Activation in the Hippocampus. |
| Q47201004 | Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. |
| Q38108433 | Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease |
| Q39193601 | An interspecies conserved motif of the mouse immune system-released activating agent (ISRAA) induces proliferative effects on human cells |
| Q90280217 | Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease |
| Q45926332 | Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions. |
| Q64904745 | Apurinic endonuclease-1 preserves neural genome integrity to maintain homeostasis and thermoregulation and prevent brain tumors. |
| Q38773714 | Aqueous and Ethanol Extracts of Australian Cane Toad Skins Suppress Pro-Inflammatory Cytokine Secretion in U937 Cells via NF-κB Signaling Pathway |
| Q36817659 | Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice |
| Q35044486 | Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex |
| Q91810640 | Attenuation in Nicotinic Acetylcholine Receptor α9 and α10 Subunit Double Knock-Out Mice of Experimental Autoimmune Encephalomyelitis |
| Q57292290 | Blood-derived plasminogen drives brain inflammation and plaque deposition in a mouse model of Alzheimer's disease |
| Q99414188 | Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice |
| Q48682603 | Cane Toad Skin Extract-Induced Upregulation and Increased Interaction of Serotonin 2A and D2 Receptors via Gq/11 Signaling Pathway in CLU213 Cells. |
| Q33595895 | Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging |
| Q50199042 | Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects. |
| Q90284925 | Continuous Inhalation Exposure to Fungal Allergen Particulates Induces Lung Inflammation While Reducing Innate Immune Molecule Expression in the Brainstem |
| Q39141602 | Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice. |
| Q36789308 | Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression? |
| Q34078917 | Cytokine targets in the brain: impact on neurotransmitters and neurocircuits |
| Q39023028 | Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer's Disease |
| Q64389910 | DNA-PK Deficiency in Alzheimer's Disease |
| Q33892330 | DNA-PK and P38 MAPK: A Kinase Collusion in Alzheimer's Disease? |
| Q41942305 | De-regulation of gene expression and alternative splicing affects distinct cellular pathways in the aging hippocampus. |
| Q39004335 | Defects in trafficking bridge Parkinson's disease pathology and genetics |
| Q89285825 | Dendritic Cells as an Alternate Approach for Treatment of Neurodegenerative Disorders |
| Q36835430 | Dnr1 mutations cause neurodegeneration in Drosophila by activating the innate immune response in the brain. |
| Q38239222 | Do the genes of the innate immune response contribute to neuroprotection in Drosophila? |
| Q41508786 | Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke. |
| Q38295210 | Effects of Physical Exercise on Neuroinflammation, Neuroplasticity, Neurodegeneration, and Behavior: What We Can Learn From Animal Models in Clinical Settings |
| Q54978764 | Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs. |
| Q38828060 | Energy metabolism and inflammation in brain aging and Alzheimer's disease. |
| Q35133505 | Extracellular proteolysis of apolipoprotein E (apoE) by secreted serine neuronal protease |
| Q92528170 | Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders |
| Q34953779 | Homeostatic and injury-induced microglia behavior in the aging brain |
| Q42174144 | IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. |
| Q27497796 | IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology |
| Q44064986 | Increased expression of toll-like receptor 4 on neurons after surgery in aged rats. |
| Q37484884 | Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein |
| Q38176535 | Inflammasomes in the CNS. |
| Q38226142 | Innate immune responses regulate morphogenesis and degeneration: roles of Toll-like receptors and Sarm1 in neurons. |
| Q38980167 | Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links. |
| Q48272369 | Interferon-β regulates the production of IL-10 by toll-like receptor-activated microglia |
| Q48152206 | Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma |
| Q58570378 | Klotho controls the brain-immune system interface in the choroid plexus |
| Q89273296 | Lauric Acid Alleviates Neuroinflammatory Responses by Activated Microglia: Involvement of the GPR40-Dependent Pathway |
| Q42563457 | Lessons learned at the intersection of immunology and neuroscience |
| Q34555277 | Long-term omega-3 supplementation modulates behavior, hippocampal fatty acid concentration, neuronal progenitor proliferation and central TNF-α expression in 7 month old unchallenged mice |
| Q47712486 | Mast cells in the brain - Old cells, new target |
| Q27009559 | Microglia centered pathogenesis in ALS: insights in cell interconnectivity |
| Q42292861 | Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. |
| Q90705188 | Mimicry of Central-Peripheral Immunity in Alzheimer's Disease and Discovery of Neurodegenerative Roles in Neutrophil |
| Q90263636 | Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer's disease |
| Q90122923 | Molecular changes associated with spinal cord aging |
| Q26770676 | Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases |
| Q90704542 | Myeloperoxidase Deficiency Inhibits Cognitive Decline in the 5XFAD Mouse Model of Alzheimer's Disease |
| Q37675611 | NETosis in Alzheimer's Disease. |
| Q52667735 | NPP1 is responsible for potent extracellular ATP hydrolysis as NTPDase1 in primary cultured murine microglia. |
| Q38693771 | Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit. |
| Q33768246 | Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. |
| Q28259238 | Neuroinflammation in Alzheimer's disease |
| Q52151909 | Neuronal Regulation of Neuroprotective Microglial Apolipoprotein E Secretion in Rat In Vitro Models of Brain Pathophysiology. |
| Q38364757 | Neuronal aggregates: formation, clearance, and spreading |
| Q50720019 | Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. |
| Q34580020 | Nuclear receptors in neurodegenerative diseases. |
| Q96155783 | Pain- and Fatigue-Related Functional and Structural Changes in Ankylosing Spondylitis: An fRMI Study |
| Q38094970 | Peripheral inflammation in neurodegeneration. |
| Q35529695 | Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models |
| Q58714026 | Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets |
| Q34508284 | Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration |
| Q37708381 | Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis |
| Q42376572 | Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation |
| Q28080292 | Role of neuroinflammation in neurodegenerative diseases (Review) |
| Q55365631 | S-Equol, a Major Isoflavone from Soybean, Inhibits Nitric Oxide Production in Lipopolysaccharide-Stimulated Rat Astrocytes Partially via the GPR30-Mediated Pathway. |
| Q43244936 | Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead |
| Q27027712 | Sorting through the roles of beclin 1 in microglia and neurodegeneration |
| Q38397575 | Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases |
| Q55405257 | Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease. |
| Q55233896 | Synaptic Failure: Focus in an Integrative View of ALS. |
| Q28353960 | TLR3 downregulates expression of schizophrenia gene Disc1 via MYD88 to control neuronal morphology |
| Q45038512 | TLR7 negatively regulates dendrite outgrowth through the Myd88-c-Fos-IL-6 pathway |
| Q38692159 | TREM2-Ligand Interactions in Health and Disease |
| Q36799584 | Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers |
| Q39243339 | Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease |
| Q30973484 | The Chemistry of Neurodegeneration: Kinetic Data and Their Implications |
| Q38676359 | The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases |
| Q38105903 | The role of inflammation in sporadic and familial Parkinson's disease |
| Q33980214 | The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution |
| Q27021382 | Therapeutic targeting of autophagy in neurodegenerative and infectious diseases |
| Q36793466 | Thinking laterally about neurodegenerative proteinopathies |
| Q48347050 | Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment |
| Q37672781 | UDP-Induced Phagocytosis and ATP-Stimulated Chemotactic Migration Are Impaired in STIM1-/- Microglia In Vitro and In Vivo. |
| Q60909466 | as a Model to Study Brain Innate Immunity in Health and Disease |
| Q47757183 | γ-Secretase in microglia - implications for neurodegeneration and neuroinflammation. |
Search more.